Public Company Platform
OTC Markets ticker GCAN.
GCAN is building an entrepreneurial public-company platform focused on strategic acquisitions, technology development, operating execution, and long-term shareholder value. The Company continues to preserve and evaluate its biotechnology intellectual property and development assets while pursuing a broader strategy designed to expand and diversify its business.
GCAN combines acquisition-oriented leadership, a public-market platform, existing technology assets, and a broader strategy for building long-term enterprise value.
OTC Markets ticker GCAN.
Flexible structures and strategic growth opportunities.
Existing biotech IP plus broader technology opportunities.
Disciplined execution and long-term value creation.
Direct access to current EDGAR filings.
TradingView market information may be delayed and is provided for general reference.
Access GCAN's current public announcements and regulatory updates through established public sources.
Review the Company's latest published press releases and public announcements through OTC Markets.
View Press Releases ↗Review current reports and other material disclosures filed by GCAN with the SEC.
View SEC FilingsGCAN is led by an acquisition-oriented executive with experience building, acquiring, operating, and restructuring businesses across multiple sectors and jurisdictions.
Mr. Sanchez Talavera is a Managing Partner of Trafalgar Asset Management, a private merchant investment firm established in 1996 that builds, acquires, and operates companies across regulated financial services, telecommunications infrastructure, restructuring, and special situations.
Under his leadership, the firm has completed transactions in excess of US$2.5 billion in aggregate transaction value. Within the TAM platform, Mr. Sanchez Talavera is the founder and controlling shareholder of Grupo Trafalgar, the firm's financial services holding company in Mexico, comprising regulated financial institutions engaged in electronic payments, deposit-taking, lending, and brokerage activities.
His experience provides GCAN with an entrepreneurial, transaction-oriented, and operationally focused perspective as the Company pursues strategic acquisitions, broader technology opportunities, and long-term value creation.
The latest GCAN filings are loaded automatically from SEC EDGAR.
| Form | Filed | Description | Filing |
|---|---|---|---|
| Loading filings... | |||
Shares of GCAN trade on the OTC Markets under the ticker symbol GCAN.
December 31.
0001695473.
391657202.
ClearTrust, LLC, 16540 Pointe Village Drive Suite 210 Lutz, Florida 33558. Telephone: (813) 235-4490.
Review the Company's strategy, technology portfolio, filings, and public announcements.
© 2026 The Greater Cannabis Company, Inc. All Rights Reserved.